With the market in uncertain territory lately, the buy signal for FCEL did not come through. The stock has been mostly down for the past week and TradeRadar clearly indicates this is not the time to buy.
As for the other two picks I have posted about, Generex (GNBT) and Eight-by-Eight (EGHT) have both slowed their advance. Generex continues to put out press releases about successes it is having with its new drug delivery systems and Eight-by-Eight recently announced that Office Max will be carrying it's products. The news is decent but the charts are weakening. An analyst announcing that he still has doubts about EGHT effectively killed a bounce-back in the making in that stock this week but I am still rating it a hold if you had purchased at the time TradeRadar gave the buy signal. I am still holding GNBT, as well.
As for the other two picks I have posted about, Generex (GNBT) and Eight-by-Eight (EGHT) have both slowed their advance. Generex continues to put out press releases about successes it is having with its new drug delivery systems and Eight-by-Eight recently announced that Office Max will be carrying it's products. The news is decent but the charts are weakening. An analyst announcing that he still has doubts about EGHT effectively killed a bounce-back in the making in that stock this week but I am still rating it a hold if you had purchased at the time TradeRadar gave the buy signal. I am still holding GNBT, as well.
Comments
Post a Comment